Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/8430
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMansurova N.N., Matchanov S.X., Sirliboyev I.A., Abdurazzakova D.S., Abduazizova N.Х., Aliyeva K.K. Nurmuhamedova N.S.-
dc.date.accessioned2023-06-15T05:43:03Z-
dc.date.available2023-06-15T05:43:03Z-
dc.date.issued2023-05-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/8430-
dc.description.abstractHozirgi kun zamonaviy tibbiyotida RA ni davolashda shu kungacha ma’lum bo‘lgan bazis yallig‘lanishga qarshi preparatlar bilan bir qatorda, yangi gen injeneriyasi usullari bilan ishlab chiqilgan dori vositalarining ham ahamiyati sezilarli darajada oshib bormoqda. Bunday preparatlar ustida olib borilgan tadqiqotlar shuni ko‘rsatadiki, ularning kasallik faolligiga ta’siri yuqori va shuning bilan bir qatorda, inson organizmiga salbiy ta’siri kamroq. Shunday dori vositalaridan biri adalimumab bo‘lib, maqolada RAli bemorlarda adalimumab bilan olib borilgan kompleks davoning bo‘g‘im destruksiyasiga ta’siri o‘rganiladi.en_US
dc.language.isootheren_US
dc.subjectrevmatoid artrit, metotreksat, adalimumab, bo‘g‘im destruksiyasi.en_US
dc.titleRevmatoidli artritda adalimumab preparati bilan olib borilgan kompleks terapiyaning bo‘g‘im destruksiyasiga ta’sirini o‘rganishen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
27.pdf1 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.